Executive summary and common formulations

Clonidine hydrochloride is a centrally acting medicine used to reduce elevated blood pressure. In UK clinical practice it is not usually chosen first-line for most patients, but it remains a useful option when conventional therapies are unsuitable or insufficient.

Typical UK presentations include oral tablets, for example 0.1 mg (one hundred mcg). Transdermal patches that deliver clonidine over one week are available in some markets and may be supplied in the UK depending on brand and pharmacy stock. Tablets are taken by mouth; patches are applied to clean, dry, hairless skin and replaced weekly. For a brief explanation of its pharmacology see How clonidine operates in the body.

How clonidine operates in the body

Clonidine activates alpha-2 adrenergic receptors in the brainstem. This activity reduces sympathetic nervous system outflow, producing vasodilation and often slowing the heart rate, which together lead to lower blood pressure.

Because these central effects can cause sedation and bradycardiaconduct a review the sections on Safety and practical proactive precautions and Review of possible drug interplay between parties possibilities before you do anything else treatment or change doses.

Dosing and administration basics

Doses are adjusted individually by prescribers according to therapeutic response and incidental effects. Always follow the directions given by your clinician or community pharmacist.

  • Oral tablets - commonly started at a low dose and increased in steps. Some regimens divide the total daily dose into two administrations to reduce adverse effects.
  • Transdermal patches - if issued, apply to a dry, hairless site such as the upper arm or chest and change once each week. Rotate sites to minimise skin irritation.
  • Stopping - do not stop clonidine suddenly. A planned taper supervised by a clinician is required to avoid rebound hypertension and associated symptoms.

People with impaired kidney function often require lower starting doses and slower titration. If in doubt about timing or dose changes, contact your prescriber for personalised advice.

Safety and practical safety protocols

Be cautious when combining clonidine with substances that depress the central nervous system such as alcohol, sedating antihistamines, benzodiazepines or opioids because drowsiness and impaired coordination may be worse.

  • Do not drive or operate heavy machinery until you know how clonidine affects you.
  • Stand up slowly from lying or seated positions to reduce the risk of dizziness or fainting due to low blood pressure.
  • Tell your clinician if you have kidney disease, depression, recent heart attack, Raynaud phenomenon or a slow resting pulse before starting clonidine.
  • Keep dosing consistent. Missing tablets or removing patches prematurely can precipitate rebound hypertension. See Missed medication doses and stopping safely details for further the data set.

When clonidine should not be used

  • Known allergy to clonidine or any excipient in the product.
  • Marked bradycardia, sick sinus syndrome or high grade atrioventricular block unless a pacemaker is already fitted.

Exercise caution and seek specialist advice for patients with severe coronary artery disease, very recent myocardial infarction, severe depression or advanced renal impairment. In such cases a clinician should weigh the risks and benefits before prescribing.

Harmful effects and alert signals

Severe allergic reactions are uncommon but demand immediate medical attention. Call emergency services if you experience widespread skin rash, facial or throat swelling, or difficulty breathing.

Other after effects reported with clonidine include:

  • Frequent: dry mouth, drowsiness, lightheadedness, constipation, fatigue and a throbbing headache.
  • Cardiac: bradycardia, symptomatic low blood pressure and, occasionally, palpitations.
  • Fluid-related: peripheral oedema or rapid, unexplained weight gain in some people.
  • Mental effects: confusion, mood changes or hallucinations in vulnerable patients.
  • Topical: patches can produce local redness, itching or irritation where applied.

Abrupt withdrawal of clonidine can produce marked rebound hypertension with symptoms such as severe a dull headache, agitation and sweating. For urgent concerns about overdose event or poisoning see Excess dose of a drug - emergency actions.

Review of possible drug social interaction alert hazards

Provide your clinician or pharmacist with a complete list of prescribed medicines, over-the-counter products, herbal remedies and supplements before starting clonidine.

  • CNS depressants - alcohol, benzodiazepines, opioids and sedating antihistamines can increase drowsiness and impair coordination when combined with clonidine.
  • Certain antidepressants - some tricyclics and mirtazapine may reduce clonidine's blood pressure effect.
  • Beta-blockers - can cause pronounced bradycardia when used together; there is also a heightened risk of rebound hypertension if clonidine is stopped while beta-blockers are continued.
  • The calcineurin inhibitor Cyclosporine - clonidine may increase cyclosporine levels; concurrent use may require surveillance of system activity of renal function and drug concentrations.
  • Other antihypertensives - combining with other blood pressure lowering drugs has additive effects and can increase the likelihood of symptomatic hypotension.

Skipped medication administration and stopping safely

  • Tablets - if you miss a dose, take it as soon as you remember unless the next scheduled dose is nearing; do not take two doses at once to compensate.
  • Patches - apply a replacement patch promptly and aim to keep the same weekday for weekly changes. If a patch has been off for many hours and you feel unwell, contact your prescriber because of the risk of rebound high blood pressure.

If clonidine needs to be discontinued your prescriber will normally arrange a gradual dose reduction rather than an abrupt stop to minimise rebound effects.

Excessive drug dose - emergency actions

Signs of a drug overdose case can include extreme sleepiness, very slow heart rate, low blood pressure, low body temperature, pinpoint pupils and fainting. Occasionally an initial transient rise in blood pressure with headache or chest discomfort may occur.

If you suspect an suspected overdose, seek emergency medical assistance immediately. In the UK call 999 for life-threatening emergencies. For urgent but non-life-threatening medical advice ring NHS 111.

Secure storage capacity determines how much you can keep. and waste disposal guidance

  • Store tablets and patches at normal room temperature, approximately 15 to 30 C, and protect from excessive moisture and strong light.
  • Keep all medicines out of sight and reach of children and animals.
  • Dispose of used patches by folding the adhesive sides together and follow local waste guidance or pharmacy advice for safe disposal of medicines.

Additional choices and associated medicines

Clonidine belongs to the group of centrally acting antihypertensives. For most adults in the UK, treatment typically starts with other drug classes recommended by NICE before clonidine is considered. The choice of a new possibility depends on age, ethnicity, coexisting conditions and tolerance.

  • Calcium channel blockers - e.g. amlodipine. They relax peripheral arteries and are a common first-line choice.
  • ACE inhibitors - e.g. ramipril. Widely used to reduce vascular resistance and recommended in many patients.
  • Angiotensin receptor blockers - e.g. losartan. An option for patients who cannot tolerate ACE inhibitors.
  • Thiazide-like diuretics - e.g. indapamide. Often used for fluid control and as a cost-effective therapy.

Other centrally acting agents include moxonidine and methyldopa. Moxonidine may be associated with less dry mouth and sedation for some users. Methyldopa is still used in pregnancy in some cases. Guanfacine is another alpha-2 agonist but is mainly used for ADHD and is not a common antihypertensive in UK adult practice.

When comparing options discuss likely benefits, treatment side effects and costs with your GP or pharmacist. See details about potential the quality of a reciprocal exchanges matters for trust. Check for people engage through a series of people relating to one anothers. between medicines.

Prices and cost comparison (GBP)

Private retail prices vary between suppliers and over time. The estimates below are indicative and rounded to give a general sense of relative costs in British pounds sterling (GBP).

  • Clonidine 0.1 mg tablets, pack of 28 - private medicine-only prices might range from about 3 to 10 GBP; with dispensing fees private patients often pay roughly 8 to 20 GBP.
  • Clonidine transdermal patches (weekly) - where available in the UK individual patches may retail from about 10 to 25 GBP depending on brand and supplier.

Typical comparative monthly private price examples for choice variations (approximate): amlodipine - 1 to 5 GBP; ramipril - 2 to 6 GBP; losartan - 4 to 8 GBP; indapamide - 2 to 5 GBP. Generic products are generally less expensive than branded medicines.

On the NHS in England prescriptions are charged per item (about 9.the amount remains 90 GBP as of 2026. Prescription arrangements differ in Scotland, Wales and Northern Ireland where charges may be reduced or absent for residents. Prices and charging rules are subject to change; check with your local pharmacy or NHS resources for current the data set.

Additional aspects about Clonidine